Basis of Presentation and Description of Business	9 Months Ended
Basis of Presentation and Description of Business	Sep. 30, 2021
Basis of Presentation and Description of Business [Abstract]
Basis of Presentation and Description of Business [Text Block]	Note 1 – Basis of Presentation and Description of Business Basis of Presentation As used in these Notes to Condensed Consolidated Financial Statements of this Quarterly Report on Form 10-Q for the period ended September 30, 2021 (the “Report”), the terms “Quaker,” “Quaker Houghton,” the “Company,” “we,” and “our” refer to Quaker Chemical Corporation (doing business as Quaker Houghton), its subsidiaries, and associated companies, unless the context otherwise requires. As used in these Notes to Condensed Consolidated Financial Statements, the term Legacy Quaker refers to the Company prior to the closing of its combination with Houghton International, Inc. (“Houghton”) (herein referred to as the “Combination”). The condensed consolidated financial statements included herein are unaudited and have been prepared in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”) for interim financial reporting and the United States Securities and Exchange Commission (“SEC”) regulations. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, the financial statements reflect all adjustments consisting only of normal recurring adjustments which are necessary for a fair statement of the financial position, results of operations and cash flows for the interim periods. The results for the nine months ended September 30, 2021 are not necessarily indicative of the results to be expected for the full year. These financial statements should be read in conjunction with the Company’s Annual Report filed on Form 10-K for the year ended December 31, 2020 (the “2020 Form 10-K”). During the three months ended September 30, 2020, the Company identified and corrected certain immaterial adjustments relating to the three months ended March 31, 2020 as well as the three and six months ended June 30, 2020. These adjustments related to the Company’s over-recognition of cost of goods sold (“COGS”) and corresponding under-recognition of inventory, as well as the associated tax impact of these adjustments, in the Company’s previously issued interim financial statements for the three months ended March 31, 2020 and the three and six months ended June 30, 2020. These adjustments impact the Company’s Americas reportable segment. The cumulative amount of reduction to COGS recorded in the three and nine months ended September 30, 2020 was approximately $ 1.7 million, with approximately $ 0.7 million related to the three months ended March 31, 2020 and approximately $ 1.0 million related to the three months ended June 30, 2020. Description of Business The Company was organized in 1918, incorporated as a Pennsylvania business corporation in 1930, and in August 2019 completed the Combination with Houghton to form Quaker Houghton. Quaker Houghton is the global leader in industrial process fluids. With a presence around the world, including operations in over 25 countries, the Company’s customers include thousands of the world’s most advanced and specialized steel, aluminum, automotive, aerospace, offshore, can, mining, and metalworking companies. Quaker Houghton develops, produces, and markets a broad range of formulated chemical specialty products and offers chemical management services (which the Company refers to as “Fluidcare”) for various heavy industrial and manufacturing applications throughout its four segments: Americas; Europe, Middle East and Africa (“EMEA”); Asia/Pacific; and Global Specialty Businesses. Hyper-inflationary economies Based on various indices or index compilations being used to monitor inflation in Argentina as well as economic instability, effective July 1, 2018, Argentina’s economy was considered hyper-inflationary under U.S. GAAP. As of, and for the three and nine months ended September 30, 2021, the Company's Argentine subsidiaries represented less than 1 % of the Company’s consolidated total assets and net sales, respectively. During the three and nine months ended September 30, 2021, the Company recorded less than $ 0.1 million and $ 0.3 million, respectively, of remeasurement losses associated with the applicable currency conversions related to Argentina. Comparatively, during the three and nine months ended September 30, 2020, the Company recorded $ 0.2 million and $ 0.3 million, respectively, of remeasurement losses associated with the applicable currency conversions related to Argentina. These losses were recorded within foreign exchange losses, net, which is a component of other income (expense), net, in the Company’s Condensed Consolidated Statements of Operations. COVID-19 Management continues to monitor the impact that the COVID-19 pandemic is having on the Company, the overall specialty chemical industry, and the economies and markets in which the Company operates. The full extent of the COVID-19 pandemic related business and travel restrictions and changes to business and consumer behavior intended to reduce its spread are uncertain as of the date of the Report as COVID-19 and the responses of governmental authorities continue to evolve globally. Further, management continues to evaluate how COVID-19-related circumstances, such as remote work arrangements, affect financial reporting processes, internal control over financial reporting, and disclosure controls and procedures. While the circumstances have presented and are expected to continue to present challenges, at this time, Management does not believe that COVID-19 has had a material impact on financial reporting processes, internal control over financial reporting, and disclosure controls and procedures. The Company cannot reasonably estimate the magnitude of the effects these conditions will have on the Company’s operations in the future as they are subject to significant uncertainties relating to the ultimate geographic spread of the virus, the incidence and severity of the symptoms, the duration or resurgences of the outbreak including the impact of new variants, the global availability, acceptance and efficacy of vaccines, the length of the travel restrictions and business closures imposed by governments of impacted countries, and the economic response by governments of impacted countries, all of which continue to evolve. To the extent that the Company’s customers and suppliers continue to be significantly and adversely impacted by COVID-19, this could reduce the availability, or result in delays, of materials or supplies to or from the Company, which in turn could significantly interrupt the Company’s business operations. Such impacts could grow and become more significant to the Company’s operations and the Company’s liquidity or financial position. Therefore, given the continuously evolving global developments with respect to this pandemic, the Company cannot reasonably estimate the magnitude or the full extent to which COVID-19 may impact the Company’s results of operations, liquidity or financial position.